Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2007
03/15/2007WO2007008627A3 Apoptosis promoters
03/15/2007WO2007001211A3 Dicarbonic acid derivatives, metastasis inhibitors and agents increasing chemotherapeutic activity of anti-tumor preparations, method for enhancing the cytostatic efficiency and metastasis process inhibiting method
03/15/2007WO2006136391A3 Treatment of solid tumor disease with combinations comprising imatinib and an efflux pump inhibitor
03/15/2007WO2006133164A3 Anti-trkb monoclonal antibodies and uses thereof
03/15/2007WO2006122954A3 Antiproliferative conjugates comprising hyaluronic acid and n-derivatives of glutamic acid
03/15/2007WO2006119968A3 Compositions and methods using microspheres and non-ionic contrast agents
03/15/2007WO2006119897A3 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12
03/15/2007WO2006106437A8 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
03/15/2007WO2005079861A3 Polymeric water soluble prodrugs
03/15/2007WO2003068169A3 Stabilized synthetic immunogen delivery system
03/15/2007US20070061901 Methods to inhibit growth of prostate cancer cells
03/15/2007US20070060647 Gene expression regulating agent
03/15/2007US20070060637 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan
03/15/2007US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
03/15/2007US20070060627 Organic compounds
03/15/2007US20070060619 Nicotinamide-based kinase inhibitors
03/15/2007US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding
03/15/2007US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
03/15/2007US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases
03/15/2007US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases
03/15/2007US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction
03/15/2007US20070060570 Sulfopyrroles
03/15/2007US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
03/15/2007US20070060553 3-Nitrogen-6,7-dioxygen steroids and uses related thereto
03/15/2007US20070060551 Methods of using isothiazole derivatives to treat cancer or inflammation
03/15/2007US20070060546 Novel use of mifepristone and derivatives therefor as hedgehog protein signaling pathway modulators and applications of same
03/15/2007US20070060521 Inhibition of STAT3 signal transduction for human cancer therapy
03/15/2007US20070060520 Use of anti-prolactin agents to treat proliferative conditions
03/15/2007US20070059836 Genetic engineering; preventing the proliferation of neoplastic cells; cancer;
03/15/2007US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
03/15/2007US20070059723 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides
03/15/2007US20070059323 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
03/15/2007US20070059317 Potent immunostimulants from microalgae
03/15/2007US20070059314 Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer
03/15/2007US20070059307 Biological products
03/15/2007US20070059305 Neutralizing human anti-IGFR antibody
03/15/2007US20070059290 Transcriptional regulation of target genes
03/15/2007US20070059279 Pharmaceutical composition for preventing or treating malignant glioma
03/15/2007US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent
03/15/2007CA2812794A1 Targeted identification of immunogenic peptides
03/15/2007CA2812110A1 Targeted identification of immunogenic peptides
03/15/2007CA2621988A1 Quinoline derivatives and use as antitumor agents
03/15/2007CA2621982A1 Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
03/15/2007CA2621879A1 Benzimidazole thiophene compounds as plk inhibitors
03/15/2007CA2621836A1 Isoquinolines as igf-1r inhibitors
03/15/2007CA2621820A1 Isoquinolines derivatives as igf-1r inhibitors
03/15/2007CA2621503A1 Triazole derivatives useful as axl inhibitors
03/15/2007CA2621470A1 Bicyclic aromatic substituted pyridone derivative
03/15/2007CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors
03/15/2007CA2621279A1 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
03/15/2007CA2621111A1 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase
03/15/2007CA2621055A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
03/15/2007CA2620472A1 Substituted benzimidazoles as kinase inhibitors
03/14/2007EP1762619A2 Multiple-tumor aberrant growth genes
03/14/2007EP1762614A2 Tumor-specific promoters
03/14/2007EP1762558A1 Process for preparing transcription factors and their use
03/14/2007EP1762242A1 MALIGNANT TUMOR INHIBITOR CONTAINING Des A FIBRIN
03/14/2007EP1762230A1 Filmtablet or granulate comprising a pyridylpyrimidine
03/14/2007EP1761566A1 Humanized anti-tag-72 monoclonal antibodies
03/14/2007EP1761560A1 Peptide-based compounds
03/14/2007EP1761539A1 Indole derivative and use for treatment of cancer
03/14/2007EP1761536A1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs
03/14/2007EP1761525A1 Thioether derivatives, their manufacture and use as pharmaceutical agents
03/14/2007EP1761515A1 2-(hetero-)aryl substituted tetrahydroquinoline derivatives
03/14/2007EP1761506A1 Substituted quinazolones as anti-cancer agents
03/14/2007EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors
03/14/2007EP1761503A2 Imidazol derivatives as tyrosine kinase inhibitors
03/14/2007EP1761485A1 Amidino compounds as cysteine protease inhibitors
03/14/2007EP1761482A1 Ortho-substituted (3-hydroxyphenyl)-acetic acid benzylidene hydrazides
03/14/2007EP1761311A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use
03/14/2007EP1761281A1 Method for treating abnormal cell growth
03/14/2007EP1761268A2 Pyrrolotriazine kinase inhibitors
03/14/2007EP1761264A1 Treatment with irinotecan (cpt-11) and an egfr-inhibitor
03/14/2007EP1581165B1 Factor viia inhibiting compounds
03/14/2007EP1515949B1 Mitotic kinesin inhibitors
03/14/2007EP1497417B1 Epha2 antigen t epitopes
03/14/2007EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same
03/14/2007EP1467706B1 Dermal application system for aminolevulinic acid-derivatives
03/14/2007EP1461063B1 Treatment of glioblastoma with thymosin-alpha 1
03/14/2007EP1385502B1 Medicament comprising an anhydrous formulation of xanthogenate
03/14/2007EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
03/14/2007EP1305434B1 A human disintegrin protein
03/14/2007EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
03/14/2007EP1227838B1 Melanoma vaccine and methods of making and using same
03/14/2007EP1224302B1 Modified viral surface proteins which bind to cells of tumor vasculature
03/14/2007EP1212068A4 Method of enhancing the efficacy of anti-tumor agents
03/14/2007EP1178999B1 L-ribo-lna analogues
03/14/2007EP1098979B1 Antibody with improved producibility
03/14/2007EP1071411B1 Topical immunostimulation to induce langerhans cell migration
03/14/2007EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
03/14/2007EP1011637B1 Modulation of drug loading in multivesicular liposomes
03/14/2007EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same
03/14/2007EP0989978B1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
03/14/2007CN1930288A Cells of which genome is modified
03/14/2007CN1930181A Helix 12 directed pharmaceutical products
03/14/2007CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
03/14/2007CN1930162A Tetrahydropyridoindole derivatives
03/14/2007CN1930156A Oxidized thioether derivatives of styryl-azoles and their use as HER tyrosine kinases inhibitors
03/14/2007CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
03/14/2007CN1930151A Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
1 ... 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 ... 2211